Q3 2026 lobbying Filed Oct 20
Q3 spend$160KQ2 $120K
QoQ+33.3%vs Q2 2026
YoY+33.3%vs Q3 2025
AgenciesCongress onlyHouse, Senate
HCRHealth IssuesMMMMedicare/Medicaid
Lobbied on Most Favored Nation Prescription Drug User Fee Act 340B Drug Pricing Program; Medicare/Medicaid Issues
Bills No bills named in Q3 2026 filings
No member trades in 90 days Stock page ›